The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
A "torpedo" filled with 165lbs of cocaine with a street value of £4.4 million has been found on an Irish beach close to a tourist hotspot.
A 76-year-old millionaire businesswoman has been taken from her car and kidnapped by an "organised gang".
A quiet and calm afternoon with many places staying dry